Weight Loss Telehealth in Delaware 15 Providers Compared for 2026

If you've been searching for weight loss telehealth in Delaware, here's the straightforward answer: 15 providers are available to you right now. That's a solid number, and it gives you real options across price points, medication types, and levels of support. The ones that do NOT operate in Delaware are Clinic Secret, Nurx, and UrWay Health, so if you've seen those mentioned elsewhere online, skip them for now and focus your research on what's actually accessible from a Delaware address.

The 15 providers serving Delaware in 2026 are Ro, Medvi, MyStart Health, Strut, Sprout Health, Eden, Peter MD, Skinny.Rx, Hers, Hims, Shed, PlushCare, Sesame Care, Henry Meds, and Ivim Health. That range covers everything from bare-bones budget platforms to full-service programs with nutritionist support and insurance navigation. The right one for you depends on whether you're paying out of pocket, whether you have insurance you want to use, and whether you want compounded or brand-name GLP-1 medication.

Delaware's regulatory environment for weight loss telehealth is relatively favorable compared to other states. Compounded semaglutide and compounded tirzepatide are both available through licensed 503B pharmacies, which matters because brand-name Wegovy and Zepbound remain difficult to obtain consistently due to supply issues. You don't have to wait for a brand-name prescription to get started here.

Delaware has full insurance parity for telehealth, meaning your insurer is required to cover an online doctor visit for weight loss at the same rate they'd cover an in-person visit. This is not the case in every state, and it's one of the most important facts a Delaware resident can know before signing up for anything. If you have employer-sponsored health insurance or a plan purchased through the Delaware marketplace, your initial consultation and follow-up visits with a telehealth provider may cost you nothing beyond your normal copay.

Delaware Medicaid also provides broader access to preventive care, including weight management services. If you're on Medicaid in Delaware, it's worth contacting your plan administrator directly before choosing a telehealth platform, because some services may be covered that you'd otherwise pay out of pocket for. PlushCare and Henry Meds are the two providers in Delaware that most actively work with insurance and Medicaid-adjacent billing, so they're the places to start if coverage is your priority.

Where insurance typically falls short is on the medication itself. Even with parity, most commercial insurance plans in Delaware cover Wegovy only under specific circumstances, usually requiring documentation of a BMI of 30 or higher, or a BMI of 27 or higher combined with a comorbidity like type 2 diabetes or hypertension. Ozempic gets covered more readily because it's labeled for diabetes, but using it off-label for weight loss is a different conversation with your insurer. Ro has built specific workflows to help with brand-name GLP-1 insurance navigation, which is why it's worth considering if you want Wegovy specifically and you have insurance that might cover it.

If cost is your main concern and you're paying out of pocket, Medvi is the most affordable all-inclusive option available in Delaware right now. Their compounded semaglutide program runs $149 to $199 per month, and that price includes the medication, the prescriber consultation, and shipping. There are no separate fees for the doctor visit or follow-up check-ins. The platform is no-frills, but the medication and clinical protocol are the same core product you're getting from more expensive providers. Medvi holds a 9.0 rating from over 33,200 verified reviews, which means the stripped-down approach hasn't hurt satisfaction.

Skinny.Rx also operates in Delaware and sits at a comparable budget price point with straightforward monthly pricing for compounded semaglutide. It's a smaller platform with about 4,378 verified reviews compared to Medvi's base, but Delaware residents who've used it tend to find the process quick and the medication consistent. If Medvi is waitlisted or has supply delays when you sign up, Skinny.Rx is the logical fallback in this price range.

Sesame Care is worth mentioning for a different kind of cost savings. It's a pay-per-visit marketplace with transparent pricing and no subscription. If you already have a primary care doctor managing your weight loss but you just need a one-time telehealth consult or a prescription review, Sesame may cost you less than signing up for a monthly program. It doesn't bundle medication, but for Delaware residents who want flexibility over commitment, that trade-off can make sense.

Delaware residents searching for semaglutide telehealth have access to both compounded and brand-name versions through the platforms listed here. Compounded semaglutide comes from licensed 503B pharmacies and is legal in Delaware where brand-name supply is constrained. In 2026, brand-name Wegovy and Ozempic supply has improved somewhat compared to prior years, but shortages still occur at the pharmacy level, and compounded formulations remain a reliable and significantly cheaper alternative for most people who qualify.

Tirzepatide follows the same pattern. Compounded tirzepatide is available through several Delaware-accessible platforms, while brand-name Zepbound is available but less consistently stocked. Tirzepatide tends to produce stronger weight loss outcomes on average in clinical data, and the compounded version brings the monthly cost down enough that it's become a popular choice. Medvi, Sprout Health, and MyStart Health all offer tirzepatide options that ship to Delaware addresses.

The clinical threshold you need to meet is a BMI of 30 or higher without any additional health conditions, or a BMI of 27 or higher if you have a comorbidity like high blood pressure, high cholesterol, sleep apnea, or type 2 diabetes. Delaware telehealth providers follow this standard, and you'll answer questions about your health history during the intake process. Most platforms give you a decision within 24 to 48 hours of completing your consultation. If you're on the borderline at BMI 27 to 29, be thorough when listing comorbidities during intake because it directly affects approval.

This is one of the most searched weight loss questions from Delaware, and the answer is yes, but with caveats. Phentermine is a Schedule IV controlled substance, and federal regulations governing how controlled substances can be prescribed via telehealth have been in a state of ongoing adjustment since the COVID-era flexibilities began expiring. As of 2026, some telehealth platforms will prescribe phentermine to Delaware residents after an initial evaluation, but not all of them do, and the ones that do typically require more documentation than they would for a non-controlled medication.

Phentermine is a shorter-term appetite suppressant, typically used for 12 weeks at a time, and it works differently from GLP-1 medications like semaglutide. It's significantly cheaper, often under $30 per month for the generic, and it's been prescribed for weight loss for decades. If you're looking for phentermine specifically, PlushCare and Peter MD are among the Delaware-accessible platforms most likely to offer it as part of a broader weight loss plan. MyStart Health also covers a range of weight loss medications that can include phentermine depending on your clinical profile.

One practical thing to know: because phentermine is a controlled substance, you may be required to have a synchronous (live video) consultation rather than an asynchronous text-based intake before it can be prescribed. That's a telehealth prescribing requirement tied to federal DEA rules, not a Delaware-specific rule, but it means your first appointment will need to happen over video rather than just filling out a form.

Medvi and Hims both carry the highest rating of 9.0 out of 10 among the 15 Delaware-available providers, but they serve very different needs. Medvi is a pure weight loss specialist at the lowest price point in Delaware, $149 to $199 per month all-inclusive, built around compounded semaglutide. Hims is a much broader platform that covers weight loss alongside ED, hair loss, and mental health, and it has a strong mobile app and one of the largest verified review bases of any telehealth platform. If weight loss is your only goal and you want the most cost-efficient option, Medvi is the cleaner choice. If you want a platform you'll use for other health needs too, Hims makes more sense.

Ro earns an 8.9 rating and is one of the most significant options for Delaware residents who want brand-name GLP-1s like Wegovy or Ozempic rather than compounded versions. Ro has built specific infrastructure for working with insurance companies to get brand-name GLP-1s covered, which is meaningful in Delaware given the state's full insurance parity. If you have insurance and want to try to get Wegovy covered, Ro's workflow is more developed for that process than most other platforms here.

For women in Delaware specifically, Hers is the most purpose-built option on the list. It holds an 8.8 rating from nearly 30,000 reviews and covers weight loss alongside women's health concerns including hormonal health, mental health, and birth control. Because Delaware's full insurance parity covers online women's health visits, some Hers consultations may fall under your existing insurance coverage. For men looking at a full health picture that includes weight loss alongside ED or testosterone concerns, Peter MD covers all of those in one place with physician-led protocols.

GLP-1 medications work best when combined with behavioral changes, and a few of the Delaware-available platforms build that support into their model. MyStart Health is positioned as the best option for people who are new to weight loss telehealth because it includes lifestyle coaching alongside the medication program. It holds an 8.6 rating from over 21,600 verified reviews, and the coaching component is what separates it from pure medication-dispatch platforms. If you've tried medication before without results, or if you want accountability alongside the prescription, MyStart is the platform to look at.

Sprout Health also includes nutritionist support as part of its personalized care plans. It operates in Delaware with compounded GLP-1 options and a higher-touch care model. The 8.5 rating from 24,800 verified reviews reflects a solid user base, and the nutritionist access is a meaningful add-on that most budget platforms don't include. Shed adds behavioral coaching to its compounded GLP-1 platform as well, though with a smaller review base of about 7,500, there's less data to go on.

Henry Meds is worth highlighting for Delaware residents who specifically have a diabetes diagnosis or a strong family history of metabolic disease. It specializes in diabetes and weight loss together, works directly with insurance for Ozempic and other GLP-1s, and approaches weight loss as a metabolic health question rather than just a cosmetic one. If your doctor has mentioned prediabetes, insulin resistance, or metabolic syndrome, Henry Meds frames the treatment in a way that may make more clinical sense for your situation than a generic weight loss platform.

If you're uninsured or your insurance doesn't cover weight loss medications, Delaware's access to compounded GLP-1s means you're not priced out of effective treatment. The cash-pay landscape in Delaware currently ranges from about $149 per month at the low end with Medvi to $300 or more per month for platforms with heavier coaching and support. Brand-name Wegovy without insurance can run $1,300 to $1,500 per month at retail, which is why compounded semaglutide at $149 to $199 is such a significant alternative for uninsured Delaware residents.

Here's a realistic monthly cost breakdown for uninsured Delaware residents based on current platform pricing: Medvi runs $149 to $199 all-inclusive. Skinny.Rx is in a similar budget range with straightforward monthly pricing. MyStart Health and Shed fall in the $200 to $300 range with coaching included. Ro, Sprout Health, and Hims vary depending on whether you're getting compounded or brand-name medication, but compounded options through those platforms typically land in the $200 to $350 range once you factor in all fees. PlushCare bills insurance when available, but its out-of-pocket consultation fee is relatively modest as a pay-per-visit model.

One thing worth knowing if you're cash-paying in Delaware: always ask the platform whether their quoted price includes medication, the consultation fee, and shipping, or whether those are billed separately. Some platforms advertise a low monthly rate but charge separately for the initial consultation or for shipping. Medvi and MyStart Health are both clear about all-inclusive pricing, which makes comparison easier. Sesame Care's pay-per-visit model also avoids subscription lock-in entirely, which some Delaware residents prefer if they want to test a platform before committing.

Delaware residents sometimes wonder whether compounded semaglutide or tirzepatide is actually legal, or whether they're doing something legally gray by ordering it. The short answer is that compounded GLP-1 medications are legally available in Delaware through licensed 503B outsourcing facilities, which are regulated by the FDA. These are not underground pharmacies. They operate under federal oversight, and the compounded medication they produce is dispensed through licensed prescribers using the same active pharmaceutical ingredient as brand-name Wegovy or Ozempic.

The reason compounded versions exist and remain available in Delaware is that FDA policy allows compounding when a drug is on the official shortage list or when a patient has a documented clinical need for a formulation that the brand-name product doesn't provide. Semaglutide and tirzepatide have been on shortage lists at various points, and FDA policy around this has evolved through 2025 and into 2026. The platforms serving Delaware that offer compounded GLP-1s, including Medvi, Sprout Health, Shed, and others, are sourcing from 503B pharmacies that operate within this regulatory framework.

What this means practically for you is that if a Delaware telehealth provider prescribes you compounded semaglutide, the medication you receive is a legitimate pharmaceutical product, not a knockoff. The dose titration protocol should be the same as what you'd follow on brand-name Wegovy. The main things you're giving up with compounded are the branded packaging, the branded pen device, and the direct manufacturer warranty on purity that comes with an FDA-approved product. For most Delaware residents paying out of pocket, that trade-off is worth $1,000 or more per month in savings.